Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Duruisseaux · SciRah

Researcher profile · Semantic Scholar

M. Duruisseaux

Share profile

M. Duruisseaux — researcher profile on SciRah

h-index: 24
Works: 85
Citations: 2,156

Most-cited papers

Efficacy of First-Line Chemotherapy in Patients with Advanced Lung Sarcomatoid Carcinoma
T. Vieira, N. Girard, M. Ung, I. Monnet +7 more
2013Journal of Thoracic Oncology200 citations Open access
Semantic Scholar
Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer.
S. Gadgeel, A. T. Shaw, R. Govindan, L. Gandhi +17 more
2016Journal of Clinical Oncology183 citations Open access
Semantic Scholar
NRG1 fusion-driven tumors: biology, detection and the therapeutic role of afatinib and other ErbB-targeting agents
J. Laskin, Stephen V. Liu, K. Tolba, C. Heining +9 more
2020Annals of Oncology157 citations Open access
Semantic Scholar
Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study
M. Duruisseaux, B. Besse, J. Cadranel, M. Pérol +17 more
2017OncoTarget154 citations Open access
Semantic Scholar
Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages.
T. Vieira, M. Antoine, C. Hamard, V. Fallet +5 more
2016Lung Cancer132 citations Open access
Semantic Scholar
Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer
A. Schram, Koichi Goto, Dong-Wan Kim, T. Macarulla +28 more
2025New England Journal of Medicine124 citations Open access
Semantic Scholar
Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
C. Comarmond, B. Crestani, A. Tazi, B. Hervier +22 more
2014Medicine93 citations Open access
Semantic Scholar
Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung.
T. Vieira, M. Antoine, A. Ruppert, V. Fallet +10 more
2014Lung Cancer79 citations
Semantic Scholar
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
E. Gobbini, A. Toffart, M. Pérol, J. Assié +25 more
2020Clinical Lung Cancer74 citations Open access
Semantic Scholar
Clinicopathologic Features and Response to Therapy of NRG1 Fusion–Driven Lung Cancers: The eNRGy1 Global Multicenter Registry
A. Drilon, M. Duruisseaux, Ji-Youn Han, M. Ito +32 more
2021Journal of Clinical Oncology70 citations Open access
Semantic Scholar
KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation.
T. Mok, Wen-Xiu Yao, M. Duruisseaux, L. Doucet +16 more
2024Journal of Clinical Oncology66 citations Open access
Semantic Scholar
Severe sotorasib-related hepatotoxicity and non-liver adverse events associated with sequential anti-PD(L)1 and sotorasib therapy in KRASG12C-mutant lung cancer.
A. Chour, J. Denis, C. Mascaux, Maéva Zysman +26 more
2023Journal of Thoracic Oncology60 citations Open access
Semantic Scholar
Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, across advanced NRG1 fusion (NRG1+) cancers.
A. Schram, K. Goto, Dong-Wan Kim, P. Martin-Romano +16 more
2022Journal of Clinical Oncology58 citations
Semantic Scholar
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series.
J. Cadranel, Stephen V. Liu, M. Duruisseaux, E. Brandén +15 more
2020The Oncologist53 citations Open access
Semantic Scholar
RET-MAP: An international multi-center study on clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion.
M. Aldea, A. Marinello, M. Duruisseaux, W. Zrafi +41 more
2023Journal of Thoracic Oncology47 citations Open access
Semantic Scholar
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions
Dong-Wan Kim, A. Schram, A. Hollebecque, K. Nishino +14 more
2024Future Oncology44 citations Open access
Semantic Scholar
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program
O. Illini, M. Hochmair, H. Fabikan, C. Weinlinger +29 more
2021Therapeutic Advances in Medical Oncology41 citations Open access
Semantic Scholar
NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma
M. Duruisseaux, A. Mcleer-Florin, M. Antoine, Sanaz Alavizadeh +5 more
2016Cancer Medicine37 citations Open access
Semantic Scholar
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations
V. Hervé, N. Rabbe, L. Guilleminault, Flora Paul +11 more
2014mAbs36 citations Open access
Semantic Scholar
Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
M. Duruisseaux, M. Antoine, N. Rabbe, A. Rodenas +7 more
2017Lung Cancer34 citations Open access
Semantic Scholar
Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy.
E. G. Leprieur, M. Antoine, T. Vieira, M. Duruisseaux +9 more
2013Lung Cancer34 citations
Semantic Scholar
[Pulmonary sarcomatoid carcinoma].
M. Antoine, T. Vieira, V. Fallet, C. Hamard +3 more
2016Annales de Pathologie28 citations
Semantic Scholar
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort.
S. Baldacci, B. Besse, V. Avrillon, B. Mennecier +20 more
2022European Journal of Cancer27 citations Open access
Semantic Scholar
The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation.
M. Duruisseaux, M. Antoine, N. Rabbe, V. Poulot +5 more
2014Lung Cancer26 citations
Semantic Scholar
Reaching multidisciplinary consensus on the management of non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer.
A. Scherpereel, E. Martin, L. Brouchet, R. Corre +6 more
2023Lung Cancer19 citations Open access
Semantic Scholar
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients
V. Gounant, M. Duruisseaux, G. Soussi, S. Van-Hulst +13 more
2021Cancers17 citations Open access
Semantic Scholar
Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma
M. Duruisseaux, N. Rabbe, M. Antoine, T. Vieira +3 more
2017ERJ Open Research17 citations Open access
Semantic Scholar
LIBELULE: a randomized phase III study to evaluate the clinical relevance of early liquid biopsy in patients with suspicious metastatic lung cancer.
Aurélie Swalduz, C. Schiffler, H. Curcio, B. Ambasager +20 more
2024Journal of Thoracic Oncology16 citations Open access
Semantic Scholar
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study
N. Girard, S. Galland-Girodet, V. Avrillon, B. Besse +18 more
2022ESMO Open16 citations Open access
Semantic Scholar
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer
F. Skoulidis, Bob T. Li, M. Hochmair, Ramaswamy Govindan +25 more
2025The Oncologist15 citations Open access
Semantic Scholar
A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumors.
A. Schram, A. Drilon, T. Macarulla, E. O'Reilly +15 more
202014 citations
Semantic Scholar
Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study
G. Bilger, A. Toffart, M. Darrason, M. Duruisseaux +16 more
2022Therapeutic Advances in Medical Oncology13 citations Open access
Semantic Scholar
Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in non-small cell lung cancer: A critical review of the literature.
Anne-Laure Désage, M. Duruisseaux, C. Lafitte, S. Bayle-Bleuez +3 more
2024Cancer Treatment Reviews12 citations Open access
Semantic Scholar
Pooled mutation analysis for the NP28673 and NP28761 studies of alectinib in ALK+ non-small-cell lung cancer (NSCLC).
O. Puig, J. Yang, S. Ou, A. Chiappori +14 more
201612 citations
Semantic Scholar
Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.
M. Duruisseaux, J. Cadranel, E. Biron, M. Pérol +2 more
2009Lung Cancer12 citations
Semantic Scholar
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis
O. Illini, F. Saalfeld, P. Christopoulos, M. Duruisseaux +44 more
2024International Journal of Molecular Sciences11 citations Open access
Semantic Scholar
LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer.
A. Swalduz, H. Curcio, B. Ambasager, Gabriel Lemoel +16 more
2023Journal of Clinical Oncology11 citations
Semantic Scholar
Is there a specific phenotype associated with the different subtypes of KRAS mutations in patients with advanced non-small-cell lung cancers?
C. Dumenil, T. Vieira, E. Rouleau, M. Antoine +6 more
2015Lung Cancer10 citations
Semantic Scholar
NRG1 fusion-positive lung cancers: Clinicopathologic profile and treatment outcomes from a global multicenter registry.
M. Duruisseaux, Stephen V. Liu, Ji-Youn Han, V. Gounant +14 more
2019Journal of Clinical Oncology9 citations
Semantic Scholar
NRG1 Fusion-Positive Lung Cancers: Clinicopathologic Profile and Treatment Outcomes from a Global Multicenter Registry
M. Duruisseaux, A. Drilon, Ji-Youn Han, V. Gounant +12 more
2019Lung Cancer9 citations
Semantic Scholar
Chemotherapy Effectiveness After First-Line Gefitinib Treatment for Advanced Lepidic Predominant Adenocarcinoma (Formerly Advanced Bronchioloalveolar Carcinoma): Exploratory Analysis of the IFCT-0401 Trial
M. Duruisseaux, L. Baudrin, E. Quoix, M. Wislez +9 more
2012Journal of Thoracic Oncology9 citations Open access
Semantic Scholar
[Pulmonary sarcomatoid carcinoma].
T. Vieira, M. Duruisseaux, A. Ruppert, J. Cadranel +2 more
2012Bulletin du Cancer9 citations
Semantic Scholar
Prognostic value of neutrophil to lymphocyte ratio and lymphocyte counts before durvalumab consolidation after radio-chemotherapy in locally advanced non-small cell lung cancer
Arnaud Colomb, B. Allignet, M. Lamkhioued, A. Swalduz +4 more
2024Radiation Oncology8 citations Open access
Semantic Scholar
The role of pemetrexed in lung adenocarcinoma, mixed subtype with bronchioloalveolar carcinoma features.
M. Duruisseaux, J. Cadranel, M. Pérol, D. Arpin
2010Current Drug Targets8 citations
Semantic Scholar
Management of sotorasib-related adverse events and hepatotoxicities following anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers and practical guidance proposal.
A. Chour, C. Basse, Fanny Lebossé, P. Bonté +2 more
2024Lung Cancer7 citations
Semantic Scholar
Knowledge-based mechanistic modeling accurately predicts disease progression with gefitinib in EGFR-mutant lung adenocarcinoma
A. L’Hostis, J. Palgen, A. Perrillat-Mercerot, E. Peyronnet +8 more
2023npj Systems Biology and Applications7 citations Open access
Semantic Scholar
Afatinib as a novel potential treatment option for NRG1 fusion-positive tumors.
J. Laskin, J. Cadranel, D. Renouf, B. Weinberg +14 more
2019Journal of Global Oncology6 citations Open access
Semantic Scholar
Factors associated with early progression of non-small-cell lung cancer treated by epidermal growth factor receptor tyrosine-kinase inhibitors
N. Rozensztajn, A. Ruppert, A. Lavolé, E. G. Leprieur +7 more
2014Cancer Medicine6 citations Open access
Semantic Scholar
Diagnosis and prognosis of acute respiratory distress syndrome related to diffuse pneumonic-type adenocarcinoma: a single-center case series study
M. Decavèle, A. Parrot, M. Duruisseaux, M. Antoine +9 more
2022Journal of Thoracic Disease5 citations Open access
Semantic Scholar
Prospective validation of in silico clinical trials prediction using an EGFR-mutated NSCLC mechanistic computational disease model.
M. Duruisseaux, P. Masson, Arnaud Nativel, Nicolas Girard +10 more
2024Journal of Clinical Oncology4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Cadranel×25
Invite
J. Cadranel — researcher profile on SciRah
M. Wislez×18
Invite
M. Wislez — researcher profile on SciRah
M. Antoine×12
Invite
M. Antoine — researcher profile on SciRah
T. Vieira×9
Invite
T. Vieira — researcher profile on SciRah

×9

Invite

N. Rabbe — researcher profile on SciRah

Invite

I. Monnet — researcher profile on SciRah

Invite

A. Drilon — researcher profile on SciRah

Invite

V. Gounant — researcher profile on SciRah

D. Moro-Sibilot×7

Invite

D. Moro-Sibilot — researcher profile on SciRah

Invite

A. Schram — researcher profile on SciRah

Invite

M. Pérol — researcher profile on SciRah

Invite

V. Poulot — researcher profile on SciRah